| Value | ₹155.0 Cr |
|---|
BSE filing, NSE: JAYKAY. Summary written from the filing by ALFA Finder's alert engine.
Jaykay Enterprises Ltd: key numbers
- Share price
- ₹195.33
- Market cap
- ₹2,746 Cr
- Revenue (annual)
- ₹239.7 Cr
- Net profit (annual)
- ₹232.5 Cr
- P/E (TTM)
- 13.8×Sector 51.5×
- Promoter holding
- 66.00%+0.81% QoQ
- FII holding
- 0.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jaykay Enterprises Ltd
All →Jaykay Enterprises Regulatory Approval
JK Digital, a Jaykay WOS, received a CDSCO licence to manufacture eight Class C/D orthopaedic and spinal implants. The lifetime licence expands the company's medical devices portfolio.
- Execution
- Lifetime
Jaykay Enterprises Other Announcement
Jaykay Enterprises Ltd has submitted its quarterly shareholding pattern report under Regulation 31(1)(b) for the period ended September 30, 2026.
Jaykay Enterprises Employee Stock Options
Jaykay Enterprises granted 13,000 stock options at Rs. 215.01 per option under its 2025 ESOP scheme. Vesting spans three years with a two-year exercise window.
Jaykay Enterprises Debt & Borrowing: ₹100 Cr
Jaykay Enterprises Limited has executed a loan agreement to provide an inter-corporate deposit of up to ₹100 Crore to its subsidiary, JK Defence & Aerospace Limited.
- Value
- ₹100.0 Cr
Jaykay Enterprises Acquisition Worth ₹25 Cr
Jaykay Enterprises acquired 25 lakh preference shares in its wholly-owned subsidiary, JK Defence & Aerospace Limited, for ₹25 Crore. This transaction involves a cash capital infusion.
- Value
- ₹25.00 Cr
Jaykay Enterprises Acquisition Worth ₹2 Cr
Jaykay Enterprises acquired additional preference shares in its wholly-owned subsidiary, JK Digital & Advance Systems, for Rs. 2 Crore.
- Value
- ₹2.00 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.